Using EGF as a positive EGFR selection marker and CD34/45 to exclude endothelial and inflammatory cells, we detected a small but distinct population of EGFR + (CD34–CD45–) cells (Fig. 6e) from five different pathological epilepsy tissues (Table 1), which we purified for downstream functional characterization of proliferation. This evidence concerns the gene CD34 and epilepsy.